Bedrosian I, Scheff A M, Mick R, Callans L S, Bucky L P, Spitz F R, Helsabeck C, Elder D E, Alavi A, Fraker D F, Czerniecki B J
Department of Surgery, Pigmented Lesion Clinic, University of Pennsylvania, Philadelphia 19104, USA.
J Nucl Med. 1999 Jul;40(7):1143-8.
Sentinel lymph node (SLN) biopsy has emerged as a novel approach for identifying patients with melanoma and regional nodal micrometastasis who may benefit from full nodal basin resection. To identify the pattern of tumor lymphatic drainage and the SLN, lymphoscintigraphy has been performed using primarily 99mTc-sulfur colloid (SC). In this study, we compare the efficacy of SLN biopsy using 99mTc-human serum albumin (HSA) with SLN biopsy after SC-based lymphoscintigraphy.
One hundred and six patients with localized cutaneous melanoma were studied. Lymphoscintigraphy was performed after intradermal injection of HSA in 85 patients and SC in 21 patients. Four patients underwent lymphoscintigraphy twice, once with SC and once with HSA. Dynamic images were acquired for up to 1 h, followed by high-count images of the SLN in various projections so that the most likely site was marked on the skin for biopsy. Intraoperatively, blue dye was injected around the primary site. Twenty-four patients underwent SLN dissection directed by preoperative lymphoscintigraphy and vital blue dye mapping; in the remaining 80 patients, a gamma probe was added intraoperatively to the localization procedure. Two patients underwent mapping with gamma probe alone.
Draining lymphatic basins and nodes were identified by lymphoscintigraphy in all patients. The SLN was identified in 95% of patients when both blue dye and intraoperative gamma probe were used. When 99mTc-HSA was used for imaging, 98% of the SLNs ultimately identified were radiolabeled, and 82% were both hot and blue. Of the SLN recovered with SC, all the nodes were radiolabeled; however, there was only 58% hot and blue concordance. Greater numbers of SLNs were removed in the SC group (median 2.0 versus 1.0, P = 0.02); however, the incidence of micrometastasis was statistically similar in both HSA and SC cohorts. In the 4 patients examined with both tracers, SLN mapping was similar.
Although SC has been the radiotracer of choice for SLN mapping in melanoma, HSA appears to be a suitable alternative, with identical success rates. In fact, the higher concordance between hot and blue nodes using HSA suggests superiority of this tracer for this purpose.
前哨淋巴结(SLN)活检已成为一种新方法,用于识别可能从全淋巴结清扫术中获益的黑色素瘤及区域淋巴结微转移患者。为确定肿瘤淋巴引流模式及前哨淋巴结,主要使用99mTc - 硫胶体(SC)进行淋巴闪烁显像。在本研究中,我们比较了使用99mTc - 人血清白蛋白(HSA)进行前哨淋巴结活检与基于SC的淋巴闪烁显像后进行前哨淋巴结活检的效果。
对106例局限性皮肤黑色素瘤患者进行研究。85例患者皮内注射HSA、21例患者皮内注射SC后进行淋巴闪烁显像。4例患者进行了两次淋巴闪烁显像,一次使用SC,一次使用HSA。采集动态图像长达1小时,随后在不同投影下获取前哨淋巴结的高计数图像,以便在皮肤上标记最可能的活检部位。术中,在原发部位周围注射蓝色染料。24例患者在术前淋巴闪烁显像和活性蓝色染料定位引导下进行前哨淋巴结清扫;其余80例患者术中在定位过程中添加了γ探测仪。2例患者仅使用γ探测仪进行定位。
所有患者通过淋巴闪烁显像均识别出引流淋巴区域和淋巴结。当同时使用蓝色染料和术中γ探测仪时,95%的患者识别出前哨淋巴结。使用99mTc - HSA进行显像时,最终识别出的前哨淋巴结中有98%被放射性标记,82%既热又呈蓝色。在通过SC回收的前哨淋巴结中,所有淋巴结均被放射性标记;然而,热区和蓝色区域的一致性仅为58%。SC组切除的前哨淋巴结数量更多(中位数分别为2.0和1.0,P = 0.02);然而,HSA组和SC组微转移的发生率在统计学上相似。在使用两种示踪剂检查的4例患者中,前哨淋巴结定位相似。
尽管SC一直是黑色素瘤前哨淋巴结定位的首选放射性示踪剂,但HSA似乎是一种合适的替代物,成功率相同。事实上,使用HSA时热区和蓝色淋巴结之间更高的一致性表明该示踪剂在此方面具有优越性。